CNS Pharmaceuticals, Inc. — Form C (Regulation Crowdfunding)
CNS Pharmaceuticals, Inc. of HOUSTON, TX filed a Form C (Regulation Crowdfunding) with the SEC on 2018-03-13. Target raise $100K, up to $1.1M. Offered through OpenDeal Inc..
Offering
- Filed: 2018-03-13
- Form: C
- Accession: 0001729427-18-000001
- Target amount: $100K
- Maximum amount: $1.1M
- Security type: Other
- Securities offered: 100,000
- Price: $1.0000
- Deadline: 2018-06-11
- Funding portal / intermediary: OpenDeal Inc.
- Intermediary file number: 007-00046
- Intermediary CRD: 283874
Issuer
- CIK: 0001729427
- Website: cnspharma.com
- Legal status: Corporation
- Organized in: NV
- Incorporated: 2017-07-27
- Address: 2100 WEST LOOP SOUTH, HOUSTON, TX, 77027
- Employees: 4
Financials (as filed)
- Total assets (most recent): $162K
- Cash (most recent): $111K
- Net income (most recent): $-219K
- Short-term debt: $122K
People (11)
| Name | Role | Location |
|---|
| Matthew Lourie | Chief Financial Officer | The Woodlands, TX |
| Christopher Downs | Chief Financial Officer | Las Vegas, NV |
| Donald H. Picker | Director | HOUSTON, TX |
| Jerzy (George) Gumulka | Director | HOUSTON, TX |
| John Climaco | Chief Executive Officer | HOUSTON, TX |
| John Climaco | Chief Executive Officer and Director | HOUSTON, TX |
| John Climaco | President, Chief Executive Officer and Director | HOUSTON, TX |
| Andrzej Andraczke | Director | HOUSTON, TX |
| Andrzej Andraczke | Directror | HOUSTON, TX |
| Jeffry Keyes | Director | Houston, TX |
| Carl Evans | Director | HOUSTON, TX |
Reg CF filing history (4)
More